Adriamycin
Term · Oncology and biomedicine · MLC-T-ONC-000277
A drug that comes from the bacterium Streptomyces peucetius and is used alone or with other drugs to treat many types of cancer, including leukemia, lymphoma, neuroblastoma, sarcoma, Wilms tumor, and certain cancers of the lung, breast, stomach, ovary, thyroid, and bladder. It is also being studied in the treatment of other types of cancer. Adriamycin damages the cell’s DNA and may kill cancer cells. It also blocks a certain enzyme needed for cell division and DNA repair. Adriamycin is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called doxorubicin hydrochloride and hydroxydaunorubicin.
| Identifier | MLC-T-ONC-000277 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | doxorubicin hydrochloride; hydroxydaunorubicin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000277",
"term": "Adriamycin",
"field": "Oncology and biomedicine",
"definition": "A drug that comes from the bacterium Streptomyces peucetius and is used alone or with other drugs to treat many types of cancer, including leukemia, lymphoma, neuroblastoma, sarcoma, Wilms tumor, and certain cancers of the lung, breast, stomach, ovary, thyroid, and bladder. It is also being studied in the treatment of other types of cancer. Adriamycin damages the cell’s DNA and may kill cancer cells. It also blocks a certain enzyme needed for cell division and DNA repair. Adriamycin is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called doxorubicin hydrochloride and hydroxydaunorubicin.",
"synonyms": [
"doxorubicin hydrochloride",
"hydroxydaunorubicin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/adriamycin/"
}
Record 480 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.